Montelukast BE study - Cmax shows supra bioavailability [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2016-12-01 15:50 (2998 d 19:13 ago) – Posting: # 16821
Views: 10,003

Hi Elam,

I am hearing you ask something like "Why is a system that divides all the world's synthetic drugs into four simple categories based on permeability and solubility not a predictor of my in vivo outcome?"
It is in my opinion the wrong question to ask.
We haven't even understood too well why BCS sometimes is a predictor.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,662 registered users;
50 visitors (0 registered, 50 guests [including 12 identified bots]).
Forum time: 11:03 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5